{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:43:12Z","timestamp":1788000192517,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1053\/j.seminoncol.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T23:52:38Z","timestamp":1398297158000},"page":"415-421","source":"Crossref","is-referenced-by-count":22,"title":["Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma Patients"],"prefix":"10.1053","volume":"41","author":[{"given":"Brian I.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1053\/j.seminoncol.2014.04.001_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Vernook","year":"2010","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1872-034X.2011.00929.x","article-title":"Recent trend of clinical features in patients with hepatocellular carcinomas","volume":"42","author":"Nagoaki","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib3","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S1590-8658(10)60508-7","article-title":"Hepatocellular carcinoma: new and emerging risks","volume":"425","author":"Sherman","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/jnci\/djr430","article-title":"Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma","volume":"103","author":"Sherman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/1055-9965.EPI-12-0124","article-title":"Socioeconomic status and hepatocellular carcinoma in the United States","volume":"21","author":"Shebl","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology\u00a0of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/cncr.22242","article-title":"Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk\u00a0for hepatocellular carcinoma","volume":"107","author":"Lu","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1746.2010.06476.x","article-title":"Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area","volume":"26","author":"Huang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0142(20010701)92:1<126::AID-CNCR1300>3.0.CO;2-V","article-title":"Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy","volume":"92","author":"Pompili","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib10","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3748\/wjg.v11.i14.2174","article-title":"Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C","volume":"11","author":"Yamanaka","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s11605-011-1538-2","article-title":"Significance of platelet counts in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria","volume":"15","author":"Amano","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib12","first-page":"77","article-title":"Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis","volume":"21","author":"Fattovich","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00535-010-0349-7","article-title":"Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus","volume":"46","author":"Kumada","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2003.08.010","article-title":"Etiology, natural history and treatment of hepatocellular carcinoma","volume":"60","author":"Colombo","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000341533","article-title":"Small hepatocellular carcinomas and thrombocytopenia","volume":"83","author":"Carr","year":"2012","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000342431","article-title":"Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma","volume":"83","author":"Carr","year":"2012","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jhep.2012.02.016","article-title":"Usefulness of alpha-fetoprotein\u00a0response\u00a0in patients treated with sorafenib for advanced hepatocellular carcinoma","volume":"57","author":"Personeni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jhep.2011.11.020","article-title":"Alpha-fetoprotein\u00a0response\u00a0correlates with EASL\u00a0response\u00a0and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis","volume":"56","author":"Memon","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gut.2004.048124","article-title":"Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre","volume":"54","author":"Grieco","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/105.1.65","article-title":"Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinic-histopathologic study of 804 North American patients","volume":"105","author":"Nzeako","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0016-5085(89)91427-3","article-title":"Hepatocellular carcinoma without cirrhosis in Japanese patients","volume":"97","author":"Okuda","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib24","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4","article-title":"Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients","volume":"75","author":"Trevisani","year":"1995","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib25","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s10620-012-2527-3","article-title":"Thrombocytosis and hepatocellular carcinoma","volume":"58","author":"Carr","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","article-title":"Thrombocytosis associated with malignant disease","volume":"114","author":"Levin","year":"1964","journal-title":"Arch Int Med"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib28","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1440-1746.2012.07148.x","article-title":"Non-cirrhotic\u00a0portal hypertension\u00a0in HIV mono-infected patients","volume":"27","author":"Jackson","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00535-007-2134-9","article-title":"Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival","volume":"43","author":"Changchien","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1872-034X.2009.00538.x","article-title":"Clinical application of an enzyme-linked immunosorbent assay detecting hepatoma-specific\u00a0gamma-glutamyltransferase","volume":"39","author":"Wang","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib31","first-page":"991","article-title":"Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study","volume":"87","author":"Xu","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib32","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor-platelet interaction in tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib33","first-page":"2747","article-title":"Blood platelets and inflammation: their relationship with liver and digestive diseases","volume":"131","author":"Ripoche","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1440-1746.2011.07044.x","article-title":"Bone marrow cells: important role in neovascularization of hepatocellular carcinoma","volume":"27","author":"Zhu","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"32","key":"10.1053\/j.seminoncol.2014.04.001_bib35","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2014.04.001_bib36","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1535-7163.MCT-06-0720","article-title":"Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer","volume":"6","author":"Stock","year":"2007","journal-title":"Mol Cancer Ther"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T18:52:36Z","timestamp":1538679156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775414001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0093775414001067"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.04.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}